Panis C - Search Results

1

NRIP1 is activated by C-JUN/C-FOS and activates the expression of PGR, ESR1 and CCND1 in luminal A breast cancer.

Binato R, Corrêa S, Panis C, Ferreira G, Petrone I, da Costa IR, Abdelhay E. Binato R, et al. Among authors: panis c. Sci Rep. 2021 Oct 27;11(1):21159. doi: 10.1038/s41598-021-00291-w. Sci Rep. 2021. PMID: 34707101 Free PMC article.

2

Label-free MSE proteomic analysis of chronic myeloid leukemia bone marrow plasma: disclosing new insights from therapy resistance.

Pizzatti L, Panis C, Lemos G, Rocha M, Cecchini R, Souza GH, Abdelhay E. Pizzatti L, et al. Among authors: panis c. Proteomics. 2012 Aug;12(17):2618-31. doi: 10.1002/pmic.201200066. Epub 2012 Aug 1. Proteomics. 2012. PMID: 22761178

3

Putative circulating markers of the early and advanced stages of breast cancer identified by high-resolution label-free proteomics.

Panis C, Pizzatti L, Herrera AC, Cecchini R, Abdelhay E. Panis C, et al. Cancer Lett. 2013 Mar 1;330(1):57-66. doi: 10.1016/j.canlet.2012.11.020. Epub 2012 Nov 28. Cancer Lett. 2013. PMID: 23200674

4

Impact of tumor removal on the systemic oxidative profile of patients with breast cancer discloses lipid peroxidation at diagnosis as a putative marker of disease recurrence.

Herrera AC, Victorino VJ, Campos FC, Verenitach BD, Lemos LT, Aranome AM, Oliveira SR, Cecchini AL, Simão AN, Abdelhay E, Panis C, Cecchini R. Herrera AC, et al. Among authors: panis c. Clin Breast Cancer. 2014 Dec;14(6):451-9. doi: 10.1016/j.clbc.2014.05.002. Epub 2014 Jun 25. Clin Breast Cancer. 2014. PMID: 25077997

5

Label-free proteomic analysis of breast cancer molecular subtypes.

Panis C, Pizzatti L, Herrera AC, Corrêa S, Binato R, Abdelhay E. Panis C, et al. J Proteome Res. 2014 Nov 7;13(11):4752-72. doi: 10.1021/pr500676x. Epub 2014 Sep 24. J Proteome Res. 2014. PMID: 25221861

6

The positive is inside the negative: HER2-negative tumors can express the HER2 intracellular domain and present a HER2-positive phenotype.

Panis C, Pizzatti L, Corrêa S, Binato R, Lemos GF, da Silva do Amaral Herrera AC, Seixas TF, Cecchini R, Abdelhay E. Panis C, et al. Cancer Lett. 2015 Feb 1;357(1):186-195. doi: 10.1016/j.canlet.2014.11.029. Epub 2014 Nov 27. Cancer Lett. 2015. PMID: 25434795

7

Early downregulation of acute phase proteins after doxorubicin exposition in patients with breast cancer.

Panis C, Pizzatti L, Bufalo AC, Herrera AC, Victorino VJ, Cecchini R, Abdelhay E. Panis C, et al. Tumour Biol. 2016 Mar;37(3):3775-83. doi: 10.1007/s13277-015-4203-7. Epub 2015 Oct 15. Tumour Biol. 2016. PMID: 26472721

8

Identifying potential markers in Breast Cancer subtypes using plasma label-free proteomics.

Corrêa S, Panis C, Binato R, Herrera AC, Pizzatti L, Abdelhay E. Corrêa S, et al. Among authors: panis c. J Proteomics. 2017 Jan 16;151:33-42. doi: 10.1016/j.jprot.2016.07.030. Epub 2016 Aug 4. J Proteomics. 2017. PMID: 27498391

9

Clinical proteomics in cancer: Where we are.

Panis C, Pizzatti L, Souza GF, Abdelhay E. Panis C, et al. Cancer Lett. 2016 Nov 28;382(2):231-239. doi: 10.1016/j.canlet.2016.08.014. Epub 2016 Aug 22. Cancer Lett. 2016. PMID: 27561426 Review.

10

Short infusion of paclitaxel imbalances plasmatic lipid metabolism and correlates with cardiac markers of acute damage in patients with breast cancer.

Panis C, Binato R, Correa S, Victorino VJ, Dias-Alves V, Herrera ACSA, Cecchini R, Simão ANC, Barbosa DS, Pizzatti L, Abdelhay E. Panis C, et al. Cancer Chemother Pharmacol. 2017 Sep;80(3):469-478. doi: 10.1007/s00280-017-3384-8. Epub 2017 Jul 8. Cancer Chemother Pharmacol. 2017. PMID: 28689298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page